SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-21-001615
Filing Date
2021-12-15
Accepted
2021-12-15 21:29:56
Documents
1
Period of Report
2021-12-14

Document Format Files

Seq Description Document Type Size
1 matinas_fm4dec142021.html 4  
1 matinas_fm4dec142021.xml 4 4149
  Complete submission text file 0000905718-21-001615.txt   5555
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-484-8805
Matinas BioPharma Holdings, Inc. (Issuer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MATINAS BIOPHARMA HOLDINGS, INC. 1545 ROUTE 206, SUITE 302 BEDMINSTER NJ 07921
Business Address
Jabbour Jerome D (Reporting) CIK: 0001698838 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38022 | Film No.: 211495778